Consequences of Disrupting the Dystrophin-Sarcoglycan Complex in Cardiac and Skeletal Myopathy
- 1 February 2007
- journal article
- review article
- Published by Elsevier in Trends in Cardiovascular Medicine
- Vol. 17 (2) , 55-59
- https://doi.org/10.1016/j.tcm.2006.12.002
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Nuclear sequestration of δ-sarcoglycan disrupts the nuclear localization of lamin A/C and emerin in cardiomyocytesHuman Molecular Genetics, 2006
- Attenuation of oxidative stress and cardiac dysfunction by bisoprolol in an animal model of dilated cardiomyopathyBiochemical and Biophysical Research Communications, 2006
- Role of Oxidative/Nitrosative Stress in the Tolerance to Ischemia/Reperfusion Injury in Cardiomyopathic Hamster HeartAntioxidants and Redox Signaling, 2006
- Bcl-2 overexpression prevents calcium overload and subsequent apoptosis in dystrophic myotubesBiochemical Journal, 2006
- Impact of sarcoglycan complex on mechanical signal transduction in murine skeletal muscleAmerican Journal of Physiology-Cell Physiology, 2006
- γ-Sarcoglycan deficiency increases cell contractility, apoptosis and MAPK pathway activation but does not affect adhesionJournal of Cell Science, 2005
- Characterization of the ATP-hydrolysing activity of α-sarcoglycanBiochemical Journal, 2004
- Dystrophin disruption in enterovirus-induced myocarditis and dilated cardiomyopathy: from bench to bedsideMedical Microbiology and Immunology, 2004
- Mouse α1-Syntrophin Binding to Grb2: Further Evidence of a Role for Syntrophin in Cell SignalingBiochemistry, 2001
- Ischemic Loss of Sarcolemmal Dystrophin and Spectrin: Correlation with Myocardial InjuryJournal of Molecular and Cellular Cardiology, 2001